Valuation: BrainCool AB

Market Cap 430M 42.97M 38.39M 35.82M 32.53M 61.27M 4.16B 61.73M 168M 2.11B 161M 158M 6.8B P/E 2026 *
-12.1x
P/E 2027 * -27.2x
Enterprise Value 391M 39.07M 34.91M 32.57M 29.59M 55.72M 3.78B 56.14M 153M 1.92B 147M 144M 6.18B EV / Sales 2026 *
8.9x
EV / Sales 2027 * 8.34x
Free-Float
67.88%
Yield 2026 *
-
Yield 2027 * -
1 day+3.42%
1 week+238.76%
Current month+238.76%
1 month+238.76%
3 months+238.76%
6 months+238.76%
Current year+238.76%
3 years 1.88
Extreme 1.88188
7.55
5 years 1.88
Extreme 1.88188
7.55
10 years 1.88
Extreme 1.88188
9.06
Manager TitleAgeSince
Chief Executive Officer 75 2026-01-13
Sales & Marketing 46 2009-12-31
Director of Finance/CFO - 2022-12-31
Director TitleAgeSince
Director/Board Member - 2022-12-31
Chairman 55 2024-12-02
Director/Board Member 64 -
Change 5-day change 1-year change 3-year change Capi.($)
+3.42%+238.76% - - 42.98M
+0.58%-0.10%-25.78%+2.04% 170B
-1.81%-0.90%-13.04%+13.82% 111B
-1.01%+0.00%-25.41%+3.22% 107B
-0.03%+1.42%-46.89%-10.61% 75.95B
+0.28%+5.66%+2.77%+70.39% 60.37B
-0.65%+6.59%+11.44%+66.40% 53.53B
-0.08%+0.65%-6.42%-32.22% 49.11B
-1.70%-2.97%-19.23%+14.57% 40.6B
+1.09%-2.31%+27.67%+1.46% 31.47B
Average +0.15%+0.25%-10.54%+14.34% 77.67B
Weighted average by Cap. -0.26%-0.04%-16.52%+11.85%

Financials

2026 *2027 *
Net sales 44M 4.39M 3.92M 3.66M 3.33M 6.26M 425M 6.31M 17.19M 216M 16.49M 16.13M 695M 48M 4.79M 4.28M 3.99M 3.63M 6.83M 464M 6.88M 18.75M 236M 17.99M 17.6M 758M
Net income -29M -2.89M -2.59M -2.41M -2.19M -4.13M -280M -4.16M -11.33M -142M -10.87M -10.63M -458M -14M -1.4M -1.25M -1.17M -1.06M -1.99M -135M -2.01M -5.47M -68.76M -5.25M -5.13M -221M
Net Debt -39M -3.89M -3.48M -3.25M -2.95M -5.55M -377M -5.59M -15.24M -192M -14.62M -14.3M -616M -30M -2.99M -2.68M -2.5M -2.27M -4.27M -290M -4.3M -11.72M -147M -11.24M -11M -474M
Projected Income Statement - Annual - BrainCool AB
Logo BrainCool AB
BrainCool AB (publ) is a Sweden-based medical device company, that specializes in the development, marketing, and sale of medical cooling systems of the human brain. The Company's technology acts as cooling pads that are applied to different parts of the patient's body, where the system controls the body temperature and other movements. Its product portfolio includes the BrainCool System, Cooral System, and RhinoChill System, offering a range of medical cooling solutions. The combination of the BrainCool and RhinoChill Systems provides care solution from pre-hospital to patient discharge. Cooral System offers solution for improving patients' quality of life and presents healthcare providers with an effective means of oral mucositis reduction. The products are used in the treatment of various severe conditions such as stroke, cardiac arrest, concussion, and migraine.
Employees
15
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Ratings Surperformance© - BrainCool AB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.090SEK
Average target price
0.8000SEK
Spread / Average Target
-26.61%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - BrainCool AB